Sai Life Sciences Limited (BOM:544306)
India
· Delayed Price · Currency is INR 1,047.95
-19.70 (-1.85%)
At close: Apr 28, 2026
Sai Life Sciences Revenue
Sai Life Sciences had revenue of 5.56B INR in the quarter ending December 31, 2025, with 26.53% growth. This brings the company's revenue in the last twelve months to 21.70B, up 39.61% year-over-year. In the fiscal year ending March 31, 2025, Sai Life Sciences had annual revenue of 16.95B with 15.66% growth.
Revenue (ttm)
21.70B
Revenue Growth
+39.61%
P/S Ratio
10.23
Revenue / Employee
6.38M
Employees
3,401
Market Cap
221.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 16.95B | 2.29B | 15.66% |
| Mar 31, 2024 | 14.65B | 2.48B | 20.38% |
| Mar 31, 2023 | 12.17B | 3.48B | 39.97% |
| Mar 31, 2022 | 8.70B | 1.10B | 14.44% |
| Mar 31, 2021 | 7.60B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hatsun Agro Product | 95.92B |
| HBL Engineering | 31.74B |
| Asahi India Glass | 48.15B |
| AstraZeneca Pharma India | 21.77B |
| Bayer CropScience | 56.21B |
| Deepak Nitrite | 79.46B |
| Sarda Energy & Minerals | 56.98B |
| Emami | 38.17B |
Sai Life Sciences News
- 2 months ago - Sai Life Sciences Transcript: Q3 25/26 - Transcripts
- 6 months ago - Sai Life Sciences Transcript: Q2 25/26 - Transcripts
- 9 months ago - Sai Life Sciences Transcript: Q1 25/26 - Transcripts
- 1 year ago - Sai Life Sciences Transcript: Q4 24/25 - Transcripts
- 1 year ago - Sai Life Sciences Transcript: Q3 24/25 - Transcripts